BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 24727660)

  • 1. Endothelin A receptor antagonism enhances inhibitory effects of anti-ganglioside GD2 monoclonal antibody on invasiveness and viability of human osteosarcoma cells.
    Liu B; Wu Y; Zhou Y; Peng D
    PLoS One; 2014; 9(4):e93576. PubMed ID: 24727660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-ganglioside GD2 monoclonal antibody synergizes with cisplatin to induce endoplasmic reticulum-associated apoptosis in osteosarcoma cells.
    Zhu W; Mao X; Wang W; Chen Y; Li D; Li H; Dou P
    Pharmazie; 2018 Feb; 73(2):80-86. PubMed ID: 29442009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GD2 ganglioside specific antibody treatment downregulates PI3K/Akt/mTOR signaling network in human neuroblastoma cell lines.
    Durbas M; Horwacik I; Boratyn E; Kamycka E; Rokita H
    Int J Oncol; 2015 Sep; 47(3):1143-59. PubMed ID: 26134970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of interactions of neuroblastoma cell lines with extracellular matrix proteins affects their sensitivity to treatment with the anti-GD2 ganglioside antibody 14G2a.
    Horwacik I; Rokita H
    Int J Oncol; 2017 May; 50(5):1899-1914. PubMed ID: 28393238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GD2 ganglioside-binding antibody 14G2a and specific aurora A kinase inhibitor MK-5108 induce autophagy in IMR-32 neuroblastoma cells.
    Durbas M; Pabisz P; Wawak K; Wiśniewska A; Boratyn E; Nowak I; Horwacik I; Woźnicka O; Rokita H
    Apoptosis; 2018 Oct; 23(9-10):492-511. PubMed ID: 30027525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis and optimization of interactions between peptides mimicking the GD2 ganglioside and the monoclonal antibody 14G2a.
    Horwacik I; Kurciński M; Bzowska M; Kowalczyk AK; Czaplicki D; Koliński A; Rokita H
    Int J Mol Med; 2011 Jul; 28(1):47-57. PubMed ID: 21455557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The GD2-specific 14G2a monoclonal antibody induces apoptosis and enhances cytotoxicity of chemotherapeutic drugs in IMR-32 human neuroblastoma cells.
    Kowalczyk A; Gil M; Horwacik I; Odrowaz Z; Kozbor D; Rokita H
    Cancer Lett; 2009 Aug; 281(2):171-82. PubMed ID: 19339105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting GD2 ganglioside and aurora A kinase as a dual strategy leading to cell death in cultures of human neuroblastoma cells.
    Horwacik I; Durbas M; Boratyn E; Węgrzyn P; Rokita H
    Cancer Lett; 2013 Dec; 341(2):248-64. PubMed ID: 23962557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Astrocyte elevated gene-1 regulates osteosarcoma cell invasion and chemoresistance via endothelin-1/endothelin A receptor signaling.
    Liu B; Wu Y; Peng D
    Oncol Lett; 2013 Feb; 5(2):505-510. PubMed ID: 23420812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knockdown of endothelin A receptor expression inhibits osteosarcoma pulmonary metastasis in an orthotopic xenograft mouse model.
    Li Y; Liao Q; Li K; Zhong D; Weng X; Mi M
    Mol Med Rep; 2012 Jun; 5(6):1391-5. PubMed ID: 22446894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A monoclonal antibody to O-acetyl-GD2 ganglioside and not to GD2 shows potent anti-tumor activity without peripheral nervous system cross-reactivity.
    Alvarez-Rueda N; Desselle A; Cochonneau D; Chaumette T; Clemenceau B; Leprieur S; Bougras G; Supiot S; Mussini JM; Barbet J; Saba J; Paris F; Aubry J; Birklé S
    PLoS One; 2011; 6(9):e25220. PubMed ID: 21966461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TWIST interacts with endothelin-1/endothelin A receptor signaling in osteosarcoma cell survival against cisplatin.
    Zhou Y; Zang X; Huang Z; Zhang C
    Oncol Lett; 2013 Mar; 5(3):857-861. PubMed ID: 23426781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selection of novel peptide mimics of the GD2 ganglioside from a constrained phage-displayed peptide library.
    Horwacik I; Czaplicki D; Talarek K; Kowalczyk A; Bolesta E; Kozbor D; Rokita H
    Int J Mol Med; 2007 May; 19(5):829-39. PubMed ID: 17390090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of anti-ganglioside GD2 mAb 14G2a in a phase I trial in pediatric cancer patients.
    Uttenreuther-Fischer MM; Huang CS; Reisfeld RA; Yu AL
    Cancer Immunol Immunother; 1995 Jul; 41(1):29-36. PubMed ID: 7641217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of endothelin A receptor in colon cancer metastasis: in vitro and in vivo evidence.
    Nie S; Zhou J; Bai F; Jiang B; Chen J; Zhou J
    Mol Carcinog; 2014 Feb; 53 Suppl 1():E85-91. PubMed ID: 23818293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of genes involved in response to doxorubicin and a GD2 ganglioside-specific 14G2a monoclonal antibody in IMR-32 human neuroblastoma cells.
    Horwacik I; Durbas M; Boratyn E; Sawicka A; Węgrzyn P; Krzanik S; Górka A; Drożniak J; Augustyniak E; Kowalczyk A; Rokita H
    Acta Biochim Pol; 2015; 62(3):423-33. PubMed ID: 26284262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelin-1 promotes osteosarcoma cell invasion and survival against cisplatin-induced apoptosis.
    Zhao Y; Liao Q; Zhu Y; Long H
    Clin Orthop Relat Res; 2011 Nov; 469(11):3190-9. PubMed ID: 21656314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of a human anti-idiotypic antibody that mimics the GD2 antigen.
    Saleh MN; Stapleton JD; Khazaeli MB; LoBuglio AF
    J Immunol; 1993 Sep; 151(6):3390-8. PubMed ID: 8376782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunization with a mimotope of GD2 ganglioside induces CD8+ T cells that recognize cell adhesion molecules on tumor cells.
    Wierzbicki A; Gil M; Ciesielski M; Fenstermaker RA; Kaneko Y; Rokita H; Lau JT; Kozbor D
    J Immunol; 2008 Nov; 181(9):6644-53. PubMed ID: 18941255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ganglioside GD2 in reception and transduction of cell death signal in tumor cells.
    Doronin II; Vishnyakova PA; Kholodenko IV; Ponomarev ED; Ryazantsev DY; Molotkovskaya IM; Kholodenko RV
    BMC Cancer; 2014 Apr; 14():295. PubMed ID: 24773917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.